
Opinion|Videos|September 18, 2024
Navigating Oligometastatic Disease: Understanding Lesion Numbers, Metastasis, and Disease Cutoffs in Clinical Practice
Author(s)Jaideep S. Sohi, MD, Jeremie Calais, MD
Jaideep Sohi, MD, and Jeremie Calais, MD, explore the complexities of managing oligometastatic disease, emphasizing the critical role of accurately assessing lesion counts, metastatic spread, and disease thresholds in optimizing clinical outcomes.
Advertisement
Video content above is prompted by the following:
- Why is it important for clinicians to recognize and understand the concept of oligometastatic disease in clinical practice?
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
A Closer Look at the Evolution and Emerging Insights with Amyloid and Tau PET for Dementia and Alzheimer’s Disease
2
Study Suggests FDG-PET Better than CT for Assessing Treatment Response for Metastatic Breast Cancer
3
Rethinking Our Approach to Acquisitions of Coronary Computed Tomography Angiography (CCTA) Scans
4
Research Highlights from SCCT 2026
5










